omeprazole has been researched along with Renal Insufficiency, Chronic in 4 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spencer, A | 1 |
| Quimby, JM | 1 |
| Price, JM | 1 |
| MacLane, S | 1 |
| Hillsman, S | 1 |
| Secoura, P | 1 |
| Steiner, JM | 1 |
| Katherine Tolbert, M | 1 |
| Lu, S | 1 |
| Zhao, J | 1 |
| Chen, X | 1 |
| Xu, S | 1 |
| Yang, X | 1 |
| Zhang, Y | 1 |
| Ma, Z | 1 |
| Jiang, H | 1 |
| Zhou, H | 1 |
| Guedes, JVM | 1 |
| Aquino, JA | 1 |
| Castro, TLB | 1 |
| Augusto de Morais, F | 1 |
| Baldoni, AO | 1 |
| Belo, VS | 1 |
| Otoni, A | 1 |
| Liu, H | 1 |
| Narayanan, R | 1 |
| Hoffmann, M | 1 |
| Surapaneni, S | 1 |
1 trial available for omeprazole and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Appetite-stimulating effects of once-daily omeprazole in cats with chronic kidney disease: Double-blind, placebo-controlled, randomized, crossover trial.
Topics: Animals; Appetite; Cat Diseases; Cats; Cross-Over Studies; Double-Blind Method; Omeprazole; Renal In | 2021 |
3 other studies available for omeprazole and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
Topics: Animals; Cytochrome P-450 CYP2E1; Indican; Lansoprazole; Mice; Omeprazole; Pantoprazole; Proteolysis | 2022 |
Omeprazole use and risk of chronic kidney disease evolution.
Topics: Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Female; Humans; Male; Middle Aged; Ome | 2020 |
The Uremic Toxin Indoxyl-3-Sulfate Induces CYP1A2 In Primary Human Hepatocytes.
Topics: Adult; Aged; Cells, Cultured; Cytochrome P-450 CYP1A2; Dose-Response Relationship, Drug; Female; Hep | 2016 |